Abstract:Background: Bacillus subtilis, an important industrial microorganism, is commonly used in the production of industrial enzymes. Genome modification is often necessary to improve the production performance of cell. The dual-plasmid CRISPR-Cas9 system suitable for iterative genome editing has been applied in Bacillus subtilis. However, it is limited by the selection of knockout genes, long editing cycle and instability. Results: To address these problems, we constructed an all-in-one plasmid CRISPR-Cas9 system, which was suitable for iterative genome editing of B. subtilis. The PEG4000-assisted monomer plasmid ligation (PAMPL) method greatly improved the transformation efficiency of B. subtilis SCK6. Self-targeting sgRNArep transcription was tightly controlled by rigorous promoter PacoR, which could induce the elimination of plasmids after genome editing and prepare for next round of genome editing. Our system achieved 100% efficiency for single gene deletions and point mutations, 96% efficiency for gene insertions, and at least 90% efficiency for plasmid curing. As a proof of concept, two extracellular protease genes epr and bpr were continuously knocked out using this system, and it only took 2.5 days to complete one round of genome editing. The engineering strain was used to express Douchi fibrinolytic enzyme DFE27, and its extracellular enzyme activity reached 159.5 FU/mL. Conclusions: We developed and applied a rapid all-in-one plasmid CRISPR-Cas9 system for iterative genome editing in B. subtilis, which required only one plasmid transformation and curing, and accelerated the cycle of genome editing. To the best of our knowledge, this is the rapidest iterative genome editing system for B. subtilis. We hope that the system can be used to reconstruct the B. subtilis cell factory for the production of various biological molecules.

Development and application of CRISPR/Cas genome editing system in the construction of prokaryotic microbial cell factories

Efficient Genome Editing in <i>Bacillus licheniformis</i> Mediated by a Conditional CRISPR/Cas9 System

CRISPR-based Gene Editing Technology and Its Application in Microbial Engineering

The application of CRISPR /Cas mediated gene editing in synthetic biology: Challenges and optimizations

CRISPeering: Bioengineering the Host Cells through CRISPRCas9 Genome Editing System as the Next-generation of Cell Factories

Development of Genome Editing and Gene Regulation Using CRISPR System

Development and application of a rapid all-in-one plasmid CRISPR-Cas9 system for iterative genome editing in Bacillus subtilis

Application of different types of CRISPR/Cas-based systems in bacteria

Metabolic Engineering of Bacterial Strains Using CRISPR/Cas9 Systems for Biosynthesis of Value-Added Products

Endogenous CRISPR-Cas System-Based Genome Editing and Antimicrobials: Review and Prospects

CRISPR-Cas-Based Engineering of Probiotics

Design and Construction of Portable CRISPR-Cpf1-Mediated Genome Editing in Bacillus subtilis 168 Oriented Toward Multiple Utilities

Strategies for Developing CRISPR‐Based Gene Editing Methods in Bacteria

Endogenous CRISPR-Cas mediated<i> in</i><i> situ</i> genome editing: State-of-the-art and the road ahead for engineering prokaryotes

Development and Characterization of a CRISPR/Cas9n-based Multiplex Genome Editing System for Bacillus Subtilis.

Development of a base editor for convenient and multiplex genome editing in cyanobacteria

Recent Advances in CRISPR/Cas9 Mediated Genome Editing in Bacillus Subtilis

CRISPR/Cas Technologies and Their Applications in Escherichia coli

Metabolic Engineering of Escherichia Coli Using CRISPR–Cas9 Meditated Genome Editing

CRISPR-based genome editing and expression control systems in Clostridium acetobutylicum and Clostridium beijerinckii.

CAMERS‐B: CRISPR/Cpf1 assisted multiple‐genes editing and regulation system for Bacillus subtilis